Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Bilirubin Blood Test Market

ID: MRFR/LS/0249-CR
148 Pages
Nidhi Mandole
Last Updated: April 24, 2026

Bilirubin Blood Test Market Research Report Information by Test Type (Total Serum Bilirubin), Product Type (Consumables and Instruments), Applications (Pediatric/Infants and Adults), End User (Hospitals, Pediatric Clinics) and Region (North America, Europe, Asia Pacific and Rest of the World (RoW)) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Test Type (USD Billion)
      1. 4.1.1 Total Serum Bilirubin (TSB)
      2. 4.1.2 Direct/Conjugated Bilirubin Test
      3. 4.1.3 Indirect/Unconjugated Bilirubin Test
    2. 4.2 Healthcare, BY Product Type (USD Billion)
      1. 4.2.1 Consumables
      2. 4.2.2 Instruments
    3. 4.3 Healthcare, BY Application (USD Billion)
      1. 4.3.1 Infants
      2. 4.3.2 Adults
    4. 4.4 Healthcare, BY End-Users (USD Billion)
      1. 4.4.1 Diagnostics Centers
      2. 4.4.2 Pathological Labs
      3. 4.4.3 Hospitals
      4. 4.4.4 Research Laboratories
      5. 4.4.5 Academic Institutions
      6. 4.4.6 Pediatric Clinics
      7. 4.4.7 Child Specialist Hospitals
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Diagnostics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ortho Clinical Diagnostics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Beckman Coulter (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mindray Medical International (CN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sysmex Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Bio-Rad Laboratories (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY TEST TYPE
    4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 US MARKET ANALYSIS BY END-USERS
    7. 6.7 CANADA MARKET ANALYSIS BY TEST TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION
    10. 6.10 CANADA MARKET ANALYSIS BY END-USERS
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY TEST TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. 6.15 GERMANY MARKET ANALYSIS BY END-USERS
    16. 6.16 UK MARKET ANALYSIS BY TEST TYPE
    17. 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE
    18. 6.18 UK MARKET ANALYSIS BY APPLICATION
    19. 6.19 UK MARKET ANALYSIS BY END-USERS
    20. 6.20 FRANCE MARKET ANALYSIS BY TEST TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    22. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION
    23. 6.23 FRANCE MARKET ANALYSIS BY END-USERS
    24. 6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    26. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION
    27. 6.27 RUSSIA MARKET ANALYSIS BY END-USERS
    28. 6.28 ITALY MARKET ANALYSIS BY TEST TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    30. 6.30 ITALY MARKET ANALYSIS BY APPLICATION
    31. 6.31 ITALY MARKET ANALYSIS BY END-USERS
    32. 6.32 SPAIN MARKET ANALYSIS BY TEST TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    34. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION
    35. 6.35 SPAIN MARKET ANALYSIS BY END-USERS
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USERS
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY TEST TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    43. 6.43 CHINA MARKET ANALYSIS BY APPLICATION
    44. 6.44 CHINA MARKET ANALYSIS BY END-USERS
    45. 6.45 INDIA MARKET ANALYSIS BY TEST TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    47. 6.47 INDIA MARKET ANALYSIS BY APPLICATION
    48. 6.48 INDIA MARKET ANALYSIS BY END-USERS
    49. 6.49 JAPAN MARKET ANALYSIS BY TEST TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    51. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION
    52. 6.52 JAPAN MARKET ANALYSIS BY END-USERS
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USERS
    57. 6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    59. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION
    60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USERS
    61. 6.61 THAILAND MARKET ANALYSIS BY TEST TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    63. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION
    64. 6.64 THAILAND MARKET ANALYSIS BY END-USERS
    65. 6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    67. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION
    68. 6.68 INDONESIA MARKET ANALYSIS BY END-USERS
    69. 6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    71. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION
    72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USERS
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    76. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION
    77. 6.77 BRAZIL MARKET ANALYSIS BY END-USERS
    78. 6.78 MEXICO MARKET ANALYSIS BY TEST TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    80. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION
    81. 6.81 MEXICO MARKET ANALYSIS BY END-USERS
    82. 6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    84. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION
    85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USERS
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USERS
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USERS
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USERS
    99. 6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    101. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION
    102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USERS
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY END-USERS, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY END-USERS, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY END-USERS, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.3.4 BY END-USERS, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.4.4 BY END-USERS, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.5.4 BY END-USERS, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.6.4 BY END-USERS, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.7.4 BY END-USERS, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.8.4 BY END-USERS, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.9.4 BY END-USERS, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.10.4 BY END-USERS, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.11.4 BY END-USERS, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.12.4 BY END-USERS, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.13.4 BY END-USERS, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.14.4 BY END-USERS, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.15.4 BY END-USERS, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.16.4 BY END-USERS, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.17.4 BY END-USERS, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.18.4 BY END-USERS, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.19.4 BY END-USERS, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.20.4 BY END-USERS, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.21.4 BY END-USERS, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.22.4 BY END-USERS, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.23.4 BY END-USERS, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.24.4 BY END-USERS, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.25.4 BY END-USERS, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.26.4 BY END-USERS, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.27.4 BY END-USERS, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.28.4 BY END-USERS, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.29.4 BY END-USERS, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
      4. 7.30.4 BY END-USERS, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Test Type (USD Billion, 2025-2035)

  • Total Serum Bilirubin (TSB)
  • Direct/Conjugated Bilirubin Test
  • Indirect/Unconjugated Bilirubin Test

Healthcare By Product Type (USD Billion, 2025-2035)

  • Consumables
  • Instruments

Healthcare By Application (USD Billion, 2025-2035)

  • Infants
  • Adults

Healthcare By End-Users (USD Billion, 2025-2035)

  • Diagnostics Centers
  • Pathological Labs
  • Hospitals
  • Research Laboratories
  • Academic Institutions
  • Pediatric Clinics
  • Child Specialist Hospitals

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions